Announcements Trials
Browse Landscape

Phase

Phase 3 8Phase 2 6Phase 4 5Phase 1/2 2Phase NA 1Phase EARLY_PHASE1 1Phase 2/3 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Sarcoma 8Osteosarcoma 3Vomiting 2Neuroectodermal Tumors, Primitive, Peripheral 2Nausea 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Sarcoma, Synovial 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neurofibrosarcoma 1Neuroblastoma 1Neoplasms, Germ Cell and Embryonal 1Neoplasms 1Medulloblastoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Liposarcoma 1Leukemia 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Hepatoblastoma 1Fibrosarcoma 1Drug-Related Side Effects and Adverse Reactions 1Dendritic Cell Sarcoma, Interdigitating 1Chemotherapeutic Agent Toxicity 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Cyclophosphamide 22fludarabine phosphate 17Cyclosporine 15Peripheral Blood Stem Cell Transplantation 14Methotrexate 14Filgrastim 14Whole-Body Irradiation 11Mycophenolic Acid 11Busulfan 11Antilymphocyte Serum 11Radiotherapy 8Melphalan 8Exercise 8Dexamethasone 8Cytarabine 8Asparaginase 8venetoclax 7blinatumomab 7Vincristine 7Etoposide 7Daunorubicin 7fludarabine 6Methylprednisolone 6Mercaptopurine 6Granulocyte Colony-Stimulating Factor 6Therapeutics 5Psychiatric Rehabilitation 5Prednisone 4Immunotherapy, Adoptive 4Cord Blood Stem Cell Transplantation 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Ifosfamide × Clear all
NCT01156883 2021-09-13

LAL1308

Gruppo Italiano Malattie EMatologiche dell'Adulto

Phase NA Completed
76 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡